Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schistosomiasis

Acta Tropica

Volumn 84, Issue 2, 2002, Pages 117-126

  Kopke Aguiar L A ^a   Martins, J R M ^a   Passerotti, C C ^a   Toledo, C F ^a   Nader, H B ^a   Borges, Durval R ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Hyaluronic acid; Liver fibrosis; Liver test; Portal hypertension; Schistosomiasis

Indexed keywords

ALPHA 2 MACROGLOBULIN; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID; PROTHROMBIN;

SCHISTOSOMIASIS;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; PORTAL HYPERTENSION; SCHISTOSOMIASIS; SPLENIC VEIN; THROMBOCYTE; VEIN DIAMETER;

ADULT; ALPHA-MACROGLOBULINS; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYALURONIC ACID; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SCHISTOSOMIASIS MANSONI; SEVERITY OF ILLNESS INDEX;

SCHISTOSOMIASIS MANSONI;

EID: 0036849466     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(02)00136-5     Document Type: Article

References (31)

1. Becker U., Deis A., Sorensen T.I.A., Gronbaek M., Borch-Johnsen K., Müller C.F., Schnohr P., Jensen G. Prediction of risk of liver disease by alcohol intake, sex and age: a prospective population study. Hepatology. 23:1996;1025-1029.
2. Borges D.R., Aguiar L.K., Toledo C.F., Martins J.R.M., Passerotti C.C., Nader H.B. Serum hyaluronate in schistosomiasis mansoni and cirrhosis. Hepatology. 32:(4 pt2):2000;419a.
3. Burchard G.D., Guissé-Sow F., Diop M., Ly A., Lanuit R., Gryseels B., Gressner A.M. Schistosoma mansoni infection in a recently exposed community in Senegal: lack of correlation between liver morphology in ultrasound and connective tissue metabolites in serum. Trop. Med. Int. Health. 3:1998;234-241.
4. Camacho-Lobato L., Borges D.R. Early liver dysfunction in schistosomiasis. J. Hepatol. 29:1998;233-240.
5. Friedman S.L. Cytokines and fibrogenesis. Sem. Liver Dis. 19:1999;129-140.
6. Gibson P.R., Fraser J.R.E., Colman J.C., Jones P.A., Jennings G., Dudley F.J. Change in serum hyaluronan: a simple index of short-term drug-induced changes in hepatic sinusoidal perfusion. Gastroenterology. 105:1993;470-474.
7. Gressner A.M. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J. Hepatol. 22:(suppl. 2):1995;28-36.
8. Grimaud J.A., Borojevic R. Chronic human schistosomiasis mansoni: pathology of the Disse's space. Lab. Invest. 36:1977;268-273.
9. Guéchot J., Poupon R.E., Poupon R. Serum hyaluronan as a marker of liver fibrosis. J. Hepatol. 22:(suppl. 2):1995;103-106.
10. Guéchot J., Serfaty L., Bonnand A.M., Chazouilléres O., Poupon R.E., Poupon R. Prognostic value of serum hyaluronan in patients with compensate HCV cirrhosis. J. Hepatol. 32:2000;447-452.
11. Hammel P., Couvelard A., O'Toole D., Ratouis A., Sauvanet A., Fléjou J.F., Degott C., Belghiti J., Bernades P., Valla D., Ruszniewski P., Lévy P. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. New Engl. J. Med. 344:2001;418-423.
12. Hascall V.C., Heinegärd D. Aggregation of cartilage proteoglycans, I. The role of hyaluronic acid. J. Biol. Chem. 249:1974;4232-4241.
13. Hassanein H.I., Zoheiry M.M.K., Voss B., El Attar G.M., Hassan S.I., Demerdash Z.A., El Baz H.M.G., Yousif A.O. Effect of early treatment with praziquantel on serum connective tissue metabolite markers in children and adolescents with intestinal schistosomiasis mansoni. Drug Res. 47:1997;84-87.
14. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 357:2001;1069-1075.
15. Jackson A.A., Phillips G., Mc Clelland I., Jahoor F. Synthesis of hepatic secretory proteins in normal adults consuming a diet marginally adequate in protein. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;G1179-G1187.
16. Kardorff R., Mugashe C., Gabone R.M., Mahlert C., Doehring E. Diagnostic value of connective tissue metabolites in Schistosoma mansoni related liver disease. Acta Trop. 73:1999;153-164.
17. Khan K.N., Yamasaki M., Yamasaki K., Inoue O., Yatsuhashi H., Koga M., Yano M. Proposed abdominal sonographic staging to predict severity of liver diseases: analysis with peritoneoscopy and histology. Dig. Dis. Sci. 45:2000;554-564.
18. Martins R.D., Borges D.R. Ethanol challenge in non-alcoholic patients with schistosomiasis. J. Clin. Pathol. 46:1993;250-253.
19. Naveau S., Poynard T., Benattar C., Bedossa P., Chaput J.C. Alpha-2-macroglobulin and hepatic fibrosis, diagnostic interest. Dig. Dis. Sci. 39:1994;2426-2432.
20. Neves M.M., Borges D.R., Vilela M.P. Concentração de etanol em bebidas alcoólicas mais consumidas no Brasil. GED. 8:1989;17-20.
21. Paranaguá-Vezozzo D.C., Cerri G.G. Duplex hemodinamic evalution of hepatoesplenic mansoni schistosomiasis. Men. Inst. Oswaldo Cruz. 87:(suppl. 4):1992;149-151.
22. Poynard T., Imbert-Bismut F., Ratziu V., Chevret S., Jardel C., Moussalli J., Messous D., Degos F., GERMED cyt04 Group. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J. Viral Hepat. 9:2002;128-133.
23. Renou C.C., Halfon P., Jouve E., Muller P., Bertrand J.J., Vitry J.M., Benderitter T. Relevance of moderate and isolate thrombopenia as a strong predictive marker of cirrhosis in patients with chronic hepatitis C virus. Hepatology. 32:2000;421A.
24. Ricard-Blum S., Hartmann D.J., Grenard P., Ravaoalimalala V.E., Boiser P., Esterre P. Relationships between several markers of extracellular matrix turn-over and ultrasonagraphy in human schistosomiasis mansoni. Am. J. Trop. Med. Hyg. 60:1999;658-663.
25. Salvaggio A., Periti M., Miano L., Tavanelli M., Marzorati D. Body mass index and liver enzyme activity in serum. Clin. Chem. 37:1991;720-723.
26. Sánchez-Rodríguez A., Criado M., Flores O., Olveira-Martín A., Martín-Oterino J.A., Esteller A. Correlation of high levels of hyaluronan and cytokines (IL-1beta, IL-6 and TGF-beta) in ascitic fluid of cirrhotic patients. Dig. Dis. Sci. 45:2000;2229-2232.
27. Shahin M., Schuppan D., Waldherr R., Risteli J., Risteli L., Savolainen E.R., Oesterling C., Rahman H.M.A., Sahly A.M.E., Razek S.M.A., Ruby O.E., Koch A., Seitz H.K. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology. 15:1992;637-644.
28. Souza M.R., Toledo C.F., Borges D.R. Thrombocytemia as a predictor of portal hypertension in schistosomiasis. Dig. Dis. Sci. 45:2000;1964-1970.
29. Truden J.L., Boros D.L. Detection of alpha 2-macroglobulin, alpha 1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of Schistosoma mansoni - infected mice. Am. J. Pathol. 130:1988;281-288.
30. Ueno T., Inuzuka S., Torimura T., Tamaki S., Koh H., Kin M., Minetoma T., Kimura Y., Ohira H., Sata M., Yoshida H., Tanikawa K. Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology. 105:1993;475-481.
31. Ultrasound in schistosomiasis. A practical guide to the standardized use of ultrasonography for the assessment of schistosomiasis-related morbidity (Report TDR/STR/SCH/00.1), 2000 WHO, Geneva, pp. 1-49.